$MEDP SEC Filings

Filed On	Filing
27 Oct 2026	144
26 Oct 2026	144
23 Oct 2026	Form 4: Burwig Susan E, Exec. VP, Operations Received 2,700 shares by exercise or conversion ($450K)
22 Oct 2026	10-Q
21 Oct 2026	8-K: Results of Operations and Financial Condition; Other Events CINCINNATI, OHIO, October 21, 2026-- Medpace Holdings, Inc. (Nasdaq: MEDP) (“Medpace”) today announced financial results for the third quarter ended September 30, 2026.
14 Oct 2026	Form 4: Burwig Susan E, Exec. VP, Operations Received 3,000 shares by exercise or conversion ($500K)
09 Oct 2026	Form 4: Burwig Susan E, Exec. VP, Operations Received 2,000 shares by exercise or conversion ($333K)
02 Oct 2026	Form 4: McCarthy Cornelius P. Iii, Director Received 28 shares by exercise or conversion
02 Oct 2026	Form 4: Carley Brian T, Director Received 36 shares by exercise or conversion
02 Oct 2026	Form 4: Kraft Robert O., Director Received 32 shares by exercise or conversion
01 Oct 2026	Form 4: Troendle August J., Director Sold 26,701 shares ($16.6M) · Sold 21,966 shares ($13.7M)
29 Sep 2026	Form 4: Troendle August J., Director Sold 154 shares ($95.6K) · Sold 2,410 shares ($1.49M)
28 Sep 2026	SCHEDULE 13D/A
25 Sep 2026	Form 4: Troendle August J., Director Sold 16,083 shares ($10.1M) · Sold 27,833 shares ($17.3M)
23 Sep 2026	Form 4: Troendle August J., Director Sold 21,883 shares ($13.6M) · Sold 49,018 shares ($30.8M)
21 Sep 2026	Form 4: Troendle August J., Director Sold 10,880 shares ($6.75M)
17 Sep 2026	Form 4: Burwig Susan E, Exec. VP, Operations Received 3,000 shares by exercise or conversion ($500K)
17 Sep 2026	Form 4: Troendle August J., Director Sold 15,971 shares ($9.92M) · Sold 8,770 shares ($5.45M)
31 Aug 2026	Form 4: Troendle August J., Director Sold 650 shares ($403K)
28 Aug 2026	Form 4: Kraft Robert O., Director Received 3,858 shares by exercise or conversion ($325K) · Sold 3,858 shares ($2.38M)

Comments